Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ Ä¡°ú °¨¿° °ü¸® ½ÃÀåÀº 2025³â¿¡ 15¾ï 5,616¸¸ ´Þ·¯¸¦ Â÷ÁöÇϰí, ¿¹Ãø ±â°£ µ¿¾È CAGR 8.59%·Î ¼ºÀåÇÏ¿© 2032³â±îÁö 27¾ï 7,065¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
Ä¡°ú ÀÇ·á ÇöÀå¿¡¼ÀÇ °¨¿° È®´ë¸¦ ¸·´Â µ¥ »ç¿ëµÇ´Â ¹æ¹ý°ú ±â¼úÀº Ä¡°ú °¨¿° °ü¸®¶ó°í ºÒ¸³´Ï´Ù. ÀÌ·¯ÇÑ ¿¹¹æ Á¶Ä¡´Â 2Â÷ ¿À¿°°ú COVID-19, HIV, °£¿°À» Æ÷ÇÔÇÑ Áúº´ÀÇ ¸¸¿¬À» ¹æÁöÇϰí ȯÀÚ¿Í ±¸° ÀÇ·á Á¾»çÀÚ¸¦ ¸ðµÎ º¸È£ÇÕ´Ï´Ù.
¼¼°èº¸°Ç±â±¸(WHO)ÀÇ Ãß°è¿¡ ÀÇÇÏ¸é ¼¼°è ¼ºÀÎÀÇ ¾à 19.0%, 10¾ï¸íÀÌ Ä¡ÁÖº´¿¡ °É¸°´Ù°í ÇÕ´Ï´Ù.
Ä¡°ú Áúȯ Áõ°¡
±¸° °¨¿°, Ä¡ÁÖº´, ÃæÄ¡ Áõ°¡¿¡ ÀÇÇØ º¸´Ù ºó¹øÇÑ Ä¡°ú °ËÁø°ú ¼ö¼úÀÌ ÇÊ¿äÇÏ°Ô µË´Ï´Ù. ÀÌ¿¡ ´ëÇÑ ¿ä±¸°¡ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, ȯÀÚ¸¦ º¸È£Çϱâ À§ÇØ Á¤ºÎ¿Í ÀÇ·á±â°üµµ ¾ö°ÝÇÑ À§»ý¹ýÀ» ½ÃÇàÇÏ°Ô µÇ¾ú½À´Ï´Ù.
ÃÖ÷´Ü °¨¿° °ü¸® Á¦Ç°ÀÇ °íºñ¿ë
¸¹Àº Ä¡°ú Áø·á¼Ò, ƯÈ÷ Áß¼Ò±Ô¸ðÀÇ Ä¡°ú Áø·á¼Ò¿¡¼ ÀÌ·¯ÇÑ °í°¡ÀÇ ±â¼úÀ» ±¸ÀÔÇÏ´Â °ÍÀº ¾î·Æ½À´Ï´Ù. Áø·á¼Ò°¡ ½Ã´ë Áö¿¬ ¶Ç´Â È¿·ÂÀÌ ¾ø´Â ±â¼ú¿¡ ÀÇÁ¸ÇÏ´Â °á°ú, ȯÀÚÀÇ ¾ÈÀüÀÌ À§ÇùµÉÁöµµ ¸ð¸¨´Ï´Ù.
½ÅÈï±¹¿¡¼ Ä¡°ú Áø·á¼Ò È®´ë
±¸° °Ç°¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö°í Ä¡°ú Ä¡·á¸¦ ¹Þ´Â »ç¶÷ÀÌ ´Ã¾î³²¿¡ µû¶ó °¨¿° °ü¸® ¼Ö·ç¼ÇÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. Ãß°¡·Î, 2Â÷ ¿À¿°À» ÇÇÇϱâ À§ÇØ, º¸´Ù ¾ö°ÝÇÑ Ã»°á ´ëÃ¥ÀÌ ½Ç½ÃµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀå¿¡ ÀÇÇØ º¸È£±¸, Ç¥¸é ¼Òµ¶Á¦, ÀÏȸ¿ë »óǰ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
±Ô°Ý ¿Üǰ ¹× À§Á¶Ç°ÀÇ À§Çè
Á¶¾ÇÇÑ Á¦Ç°À̳ª À§Á¶Ç°Àº Á¾Á¾ ¾ÈÀü¼º°ú ±ÔÁ¦ ¿ä°ÇÀ» ÃʰúÇÏÁö ¾Ê±â ¶§¹®¿¡ °¨¿° ÀüÆÄÀÇ À§ÇèÀÌ ³ô¾ÆÁý´Ï´Ù. À§Á¶Ç°Àº ½ÃÀå ¿ªÇÐÀ» º¯È½ÃÄÑ Á¤±Ô¾÷ÀÚÀÇ °æÀïÀ» °ï¶õÇÏ°Ô ÇÕ´Ï´Ù.
COVID-19ÀÇ ¿µÇâ
COVID-19ÀÇ ´ëÀ¯ÇàÀº Ä¡°ú °¨¿° °ü¸® ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. Àå±âÀûÀÎ ¼ö¿ä¸¦ ²ø¾î¿Ã·È½À´Ï´Ù. ±ÔÁ¦±â°üÀÌ º¸´Ù ¾ö°ÝÇÑ °¡À̵å¶óÀÎÀ» µµÀÔÇÏ¿©, Áø·á¼Ò°¡ ¾ÈÀü ´ëÃ¥À» °ÈÇÏ°Ô µÇ¾ú½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ¼ö¼ú¿ë µå·¹ÀÌÇÁ ºÎ¹®ÀÌ ÃÖ´ë°¡ µÉ Àü¸Á
¼ö¼ú¿ë µå·¹ÀÌÇÁ ºÐ¾ß´Â Ä¡°ú Ä¡·á Áß ¹«±Õ ȯ°æÀ» Á¦°øÇÔÀ¸·Î½á ¿¹Ãø ±â°£ µ¿¾È ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÏȸ¿ë µå·¹ÀÌÇÁ¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ±â¼úÀÇ Áøº¸¿¡ ÀÇÇØ ³»¾×¼º µå·¹ÀÌÇÁ³ª Ç×±Õ¼º µå·¹ÀÌÇÁ°¡ °³¹ßµÇ¾î, °¨¿° °ü¸® È¿À²ÀÌ Çâ»óÇϰí ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È CAGRÀÌ °¡Àå ³ôÀº °ÍÀº Ä¡°ú ±â°ø¼Ò ºÐ¾ß·Î ¿¹»óµË´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È Ä¡°ú ±â°ø¼Ò ºÐ¾ß´Â °¡Àå ³ôÀº ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±× °á°ú ¸ê±Õ Àåºñ, Ç¥¸é ¼Òµ¶Á¦ ¹× °³Àκ¸È£±¸(PPE)°¡ Ç×»ó ÇÊ¿äÇÕ´Ï´Ù.
¿¹Ãø±â°£ µ¿¾È ±¸°À§»ý¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡, Ä¡°úÄ¡·á Áõ°¡, ÀÇ·áÀÎÇÁ¶óÀÇ È®´ë¿¡ ÀÇÇØ ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¸ê±Õ±â±âÀÇ ±â¼úÀû Áøº¸¿Í Ä¡°úÀÇ¿ø ¼ö Áõ°¡°¡ ½ÃÀå ħÅõ¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¤ºÎÀÇ Àû±ØÀûÀÎ ´ëó³ª °¨¿° °ü¸®¿¡ °üÇÑ Àü¹®ÀûÀÎ Æ®·¹ÀÌ´× Áõ°¡°¡ ÀÌ Áö¿ª ½ÃÀå È®´ë¸¦ ÇÑÃþ ´õ °¡¼Ó½Ã۰í ÀÖ¾î, ¼¼°èÀÇ ±â¾÷¿¡ ÀÖ¾î¼ Áß¿äÇÑ ±âȸ°¡ µÇ°í ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì´Â Ä¡°ú Ä¡·á°¡ Áõ°¡ÇÔ¿¡ µû¶ó °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Ä¡°ú ÀÇ·á Á¾»çÀÚµé »çÀÌ¿¡¼ °¨¿° °ü¸® ÇÁ·ÎÅäÄÝÀ» ÃßÁøÇÏ´Â ±³À° ÀÌ´Ï¼ÅÆ¼ºêµµ ½ÃÀå °³Ã´¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
According to Stratistics MRC, the Global Dental Infection Control Market is accounted for $1556.16 million in 2025 and is expected to reach $2770.65 million by 2032 growing at a CAGR of 8.59% during the forecast period. The methods and techniques used to stop infections from spreading in dental settings are referred to as dental infection control. It entails upholding a sterile and clean workplace, wearing personal protection equipment (PPE), sterilising tools appropriately, and adhering to stringent hygiene guidelines. These precautions guard against cross-contamination and the spread of illnesses including COVID-19, HIV, and hepatitis, protecting both patients and oral healthcare providers. In order to maintain public confidence in dental care and to guarantee high standards in clinical practice, health authorities regulate effective infection control, which is crucial for patient safety.
According to the estimation of the World Health Organization (WHO), around 19.0% or 1.0 billion adults globally are affected by periodontal diseases.
Rising incidence of dental disorders
A rise in oral infections, periodontal disorders, and tooth decay necessitates more frequent dental checkups and operations. The requirement for stringent infection prevention procedures in dental clinics is increased by this increase in patient traffic. Consequently, there is an increasing need for personal protective equipment, disinfectants, and sterilisation supplies. To protect patients, governments and medical institutions are also enforcing strict hygiene laws. As a result, dental offices are spending more on cutting-edge infection control products, which is driving market growth.
High cost of advanced infection control products
It is difficult for many dental clinics, particularly small and mid-sized ones, to afford these pricey technologies. This restricts the use of contemporary disinfectants, protective gear, and sterilisation equipment. Access to necessary infection control procedures is further limited in developing regions by the financial load. Patient safety may be jeopardised as a result of clinics depending on antiquated or ineffective techniques. All things considered; the expense deters the broad adoption of strict infection control procedures.
Expanding dental clinics in emerging economies
The need for infection control solutions is rising as more people seek dental treatment as a result of growing awareness of oral health. Sterilisation and disinfection solutions are becoming more and more necessary as a result of government and private sector investments in dental infrastructure. Clinics are implementing more stringent cleanliness measures to avoid cross-contamination as patient traffic increases. The demand for protective gear, surface disinfectants, and disposable goods is increased by this growth. In general, the market for infection control products in these areas is directly increased by the expanding number of dental offices.
Risk of substandard or counterfeit products
The risk of infection transmission is increased when inferior or fake goods are present since they frequently don't exceed safety and regulatory requirements. Dental practitioners that use inefficient products risk legal repercussions and harm to their reputation. By providing cheaper pricing, counterfeit goods also alter market dynamics and make it harder for legitimate firms to compete. As a result, there is less money spent on industry research and innovation. In general, the possibility of fake goods reduces consumer trust and impedes market expansion.
Covid-19 Impact
The COVID-19 pandemic significantly impacted the dental infection control market. With dental clinics temporarily closed and elective procedures postponed, demand for dental infection control products declined initially. However, heightened awareness of infection prevention boosted long-term demand for personal protective equipment (PPE), disinfectants, and sterilization products. Regulatory bodies introduced stricter guidelines, prompting clinics to upgrade safety measures. The market experienced a shift towards single-use products and advanced hygiene protocols, ultimately driving innovation and sustained growth in infection control practices post-pandemic.
The surgical drapes segment is expected to be the largest during the forecast period
The surgical drapes segment is expected to account for the largest market share during the forecast period by providing a sterile environment during dental procedures. These drapes act as a barrier, minimizing the risk of cross-contamination between patients and dental professionals. With the rise in dental surgeries and awareness of infection prevention, the demand for high-quality, disposable drapes has surged. Technological advancements have led to the development of fluid-resistant and antimicrobial drapes, enhancing infection control efficiency. Moreover, stringent regulatory guidelines in healthcare settings further boost the adoption of surgical drapes in dental practices.
The dental laboratories segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the dental laboratories segment is predicted to witness the highest growth rate, due to the high demand for infection control products during prosthetic and orthodontic procedures. These labs handle various dental appliances, increasing the risk of cross-contamination and thus requiring stringent hygiene protocols. As a result, there is a consistent need for sterilization equipment, surface disinfectants, and personal protective equipment. Technological advancements in lab procedures also drive the adoption of more efficient infection control solutions. Moreover, the growing number of dental labs worldwide contributes to the expanding market demand.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to increasing awareness about oral hygiene, rising dental procedures, and expanding healthcare infrastructure. Countries like China, India, Japan, and South Korea are driving demand with growing populations and heightened focus on patient safety. Technological advancements in sterilization equipment and the rising number of dental clinics are boosting market penetration. Additionally, supportive government initiatives and increased professional training in infection control practices are further accelerating market expansion across the region, making it a key area of opportunity for global players.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to increasing dental procedures. Technological advancements in sterilization equipment and disinfectants are enhancing the efficiency of infection control practices. The presence of major market players, coupled with growing investments in dental infrastructure and patient safety, supports market expansion. Educational initiatives promoting infection control protocols among dental professionals also contribute to the market's development. Overall, the region shows strong potential for continued innovation and adoption of advanced infection control solutions.
Key players in the market
Some of the key players profiled in the Dental Infection Control Market include Dentsply Sirona, 3M, Steris Corporation, Midmark Corporation, KaVo Kerr, Hu-Friedy, Coltene Holding AG, Crosstex International, Inc., Biotrol, Dentisan, GC America Inc., Kerr Corporation, Danaher Corporation, Patterson Companies, Inc., Planmeca Oy, Young Innovations, SciCan Ltd. and Tuttnauer.
In April 2024, 3M completed the spin-off of its healthcare division, forming Solventum Corporation. This new entity encompasses 3M's businesses in wound and oral care, health informatics, and biopharmaceutical filtration.
In January 2024, Dentsply Sirona entered a four-year partnership with iADH, aligning with its sustainability strategy "BEYOND: Taking Action for a Brighter World." The collaboration focuses on raising awareness and improving dentistry for people with disabilities.